Join
Live feed
·
PRReleasevia Quantisnow
Evolus Inc. logo

"Extra-Strength" Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Interim Phase II Data Results, Representing Prolonged 6-Month Performance

ByQuantisnow·Wall Street's wire, on your screen.
EOLS· Evolus Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EOLS (Evolus Inc.) and more on Quantisnow.